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Bulimia: Medical Complications
PHILIP S. MEHLER, M.D.,1,2 CYNTHIA CREWS, M.D.,1,2 and KENNETH WEINER, M.D.3,4

ABSTRACT
Bulimia nervosa is a common eating disorder that predominantly affects young women. There
are three main models of purging in bulimia. Resulting medical complications are related to
the particular mode and frequency of purging. Commonly, there are oral and gastrointestinal
complications along with serious electrolyte and endocrine complications. The majority of
the medical complications of bulimia nervosa are treatable if diagnosed in a timely fashion.
Some of these patients require inpatient hospitalization, and others can be managed along a
continuum of outpatient care. The American Psychiatric Association has comprehensive treatment guidelines for the management of bulimia. Primary care physicians and gynecologists
need to be familiar with this disorder and its medical implications.
INTRODUCTION

B

ULIMIA NERVOSA WAS FIRST IDENTIFIED as a distinct disorder by Gerald Russell, M.D., in the
late 1970s.1 As with anorexia nervosa, bulimia
nervosa is an illness that afflicts primarily young
females ages 12–35, although recently there has
been an increased incidence in women in midlife.
The reported lifetime prevalence of anorexia nervosa in females ranges form 0.5% to 3.7%.2,3 In
comparison, bulimia nervosa has a lifetime
prevalence of 1%–4% and may be as high as 19%
in certain select groups of female college students.4–6 These numbers may be misleading,
however, because many more persons are afflicted with eating disorders that fall short of the
formal diagnostic criteria for bulimia nervosa or
anorexia nervosa but are no less debilitating.
Binge eating (similar to bulimia nervosa except it

lacks the purging component), for example, has
been reported in close to 80% of female college
undergraduates. The ratio of female/male patients is in the range of 10:1–20:1.

DIAGNOSTIC CRITERIA
Although there are a few physical and laboratory findings that are strongly suggestive of bulimia nervosa, the diagnosis is based on specific
behavioral criteria (Table 1). A high index of suspicion in the right clinical setting, together with
sensitivity and respect for the patient, will aid the
clinician in eliciting the historical features necessary for making the diagnosis. The high prevalence of this disorder in young women would
seem to mandate routine screening in this population, although this has not yet been established
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TABLE 1.

DSM-IV CRITERIA

FOR

BULIMIA NERVOSAa

Binge eating (2 times/week for 3 months)
Purging or other compensatory weight loss measures
(2 times/week for 3 months)
Regular self-induced vomiting or misuse of laxatives or
diuretics in the purging type; other inappropriate
compensatory behavior, such as fasting or excessive
exercise, in the nonpurging type
Self-image unduly influenced by body weight or shape
Absence of anorexia nervosa
aAmerican Psychiatric Association. Diagnostic and
Statistical Manual of Mental Disorders, 4th ed. Washington,
DC: APA, 1994.

as the standard of care. There are, however, a few
recently developed screening questionnaires that
seem to have reasonable utility to diagnose bulimia.7 According to the American Psychiatric Association’s Diagnostic and Statistical Manual of
Mental Disorders, 4th edition (DSM-IV), bulimia
nervosa is characterized by recurrent episodes of
binge eating and purging or other compensatory
weight loss behaviors occurring at least twice a
week for 3 months, an undue influence of body
shape and weight on self-image, and the occurrence of these behaviors at times other than during episodes of anorexia nervosa.8
There are two subtypes of bulimia nervosa,
purging and nonpurging. The purging type is
characterized by self-induced vomiting or the use
of laxatives or diuretics to induce weight loss and
counteract the sequelae of binge eating. The nonpurging type, in contrast, is characterized by fasting or engaging in excessive exercise and the
compensatory behaviors for avoiding weight
gain from binge eating episodes. To meet clinical
criteria according to DSM-IV, binges and the resulting compensatory behavior must occur at a
minimum of two times a week for a period of 3
months. Variants that do not clearly fall into either category include the use of diet pills or thyroid hormone, chewing and spitting out food,
and in the case of patients with diabetes mellitus,
skipping insulin doses to induce an osmotic diuresis and weight loss.
Bulimia nervosa frequently shares company
with other psychiatric disorders, including substance abuse, depression, bipolar disorder, anxiety disorders, and posttraumatic stress disorder
(PTSD) (up to 37%).9–12 In fact, their inherent
compulsiveness predisposes these patients to
other addictive psychosocial behaviors, such as
stealing, drug abuse, and alcohol dependence.13

When present, these comorbid conditions need to
be diagnosed and treated effectively to maximize
treatment outcomes in individuals suffering from
an eating disorder. The complexity of these patients is best served by a multidisciplinary treatment team.14
Weight preoccupation is a primary symptom in
both anorexia nervosa and bulimia nervosa, and
many patients demonstrate a mixture of both
anorexic and bulimic symptoms. Up to 50% of
patients with anorexia nervosa develop bulimic
symptoms, and some patients who are initially bulimic develop anorexic symptoms.15 The risk of
death in bulimia is substantially lower than that in
anorexia nervosa, but it is still higher than in agematched females in the population as a whole.16
The pathogenesis of bulimia nervosa can be
best understood using a biopsychosocial model.
Genetic studies have identified a clear biological
basis for eating disorders, and, in fact, anorexia
nervosa is as inheritable as schizophrenia. If a woman’s mother or sister has anorexia nervosa, her
lifetime incidence is 12 times greater than the
norm for developing anorexia nervosa and 4
times greater than the norm for developing bulimia nervosa. However, it is clear that although
genetics may load the gun, life—that is, family,
trauma, dieting, social pressures, western media/advertising—pulls the trigger. Many patients have been exposed to teasing about their
body shape, and often these patients have the
trait of excessive perfectionism and the negative
self-evaluation with which it is associated.17

MEDICAL COMPLICATIONS
There are three main modes of purging: selfinduced vomiting, abuse of laxatives, and misuse
of diuretics. Most patients with bulimia induce
vomiting with their finger, but some use ipecac.
As the illness progresses, many can simply turn
their heads and vomit reflexively without mechanical stimulation. The laxatives abused are the
stimulant type containing bisacodyl, cascara, or
senna. Diuretic preparations and diet pills, such
as those containing ephedrine, are used less frequently. The medical complications of bulimia
nervosa are related to the mode and frequency of
purging, whereas in anorexia nervosa, they arise
as a result of starvation (restricting) and weight
loss (Table 2).
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TABLE 2.

MEDICAL COMPLICATIONS

Renal
Hypokalemia
Hyperchloremic metabolic acidosis
Hyperamylasemia
Nonanion gap metabolic acidosis
Pseudo-Bartter’s syndrome
Idiopathic edema
Oral
Perimolysis
Sialadenosis
Xerostomia
Oral mucosal erythema
Cheilitis
Gastrointestinal
Esophagitis
Dyspepsia
Gastroesophageal reflux disease
Esophageal rupture
Melanosis coli
Atonic colon
Cathartic colon
Steatorrhea
Protein-losing gastroenteropathy
Gastrointestinal bleeding

In a study involving 275 women with bulimia
nervosa, the most common symptoms were
weakness (83.6%), feeling bloated (75.2%), puffy
cheeks (50.1%), dental problems (36.5%), and finger calluses (27.4%).18

Renal and electrolyte abnormalities
A number of electrolyte and acid-base abnormalities may result from bulimia nervosa, depending on whether the method of purging used
is self-induced vomiting, diuretic misuse, or laxative abuse. Hypokalemia is the most serious abnormality, as it may cause cardiac arrhythmias,
rhabdomyolysis, muscle weakness, hypokalemic
cardiomyopathy, and tetany. The prevalence of
hypokalemia is low and occurs in 4.6% of bulimic
patients; it is primarily found in lower-weight bulimics who vomit or use laxatives or both.19 Given
its low sensitivity, screening for hypokalemia
cannot be recommended as a means of detecting
bulimia nervosa because its absence does not exclude the diagnosis. On the other hand, finding
hypokalemia in an otherwise healthy young woman is very specific for bulimia nervosa and suggests daily vomiting or diuretic abuse.
Several mechanisms contribute to the development of hypokalemia in bulimia nervosa. There
is a direct loss of potassium as a result of vomiting. The concomitant loss of chloride ions and gas-

OF

BULIMIA

Cardiovascular
Hypotension
Syncope
Arrhythmias
Cardiomyopathy
Mitral valve prolapse
Endocrine
Irregular menses
False positive dexamethasone
suppression test
Hypoglycemia
Diabetes mellitus

tric acid leads to a hypokalemic-hypochloremic
metabolic alkalosis. Laxative abuse causes loss of
potassium and bicarbonate in the stool, resulting
in hypokalemia and a nonanion gap metabolic acidosis. Some diuretics cause renal wasting of
potassium. The more significant cause of hypokalemia is activated when purging of any type
results in a significant degree of volume depletion. Then, the renal renin-angiotensin hormonal
system is activated, leading to high ambient levels of these hormones. These, in turn, drive the renal retention of sodium in exchange for loss of hydrogen and potassium ions, which are excreted in
the urine. This results in a metabolic alkalosis in
bulimic patients who purge excessively through
either self-induced vomiting or diuretic abuse.
The most severe cases of metabolic alkalosis are
seen with self-induced vomiting (Table 3).
The normotensive, hypokalemic, hypochloremic metabolic alkalosis seen in many patients
with bulimia is known as pseudo-Bartter’s syndrome and has significant therapeutic implications. Specifically, the efficacy of potassium repletion is abrogated unless there is concomitant
normalization of the hypovolemic state.20,21 On
occasion, a bulimic patient will seek care in an
emergency room and be found to have severe
hypokalemia. Despite massive amounts of potassium repletion, such patients remain hypokalemic because their fluid status has not been
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TABLE 3.

ELECTROLYTE VALUES USUALLY ASSOCIATED

WITH

PURGING

Serum
Purging
method
Vomiting
Laxative use
Diuretic use

Sodium
(138–147
mmol/L)

Potassium
(3.7–5.2
mmol/L)

Chloride
(101–112
mmol/L)

Bicarbonate
(22–28
mmol/L)

Increased,
Decreased Decreased Increased
decreased,
normal
Increased,
Decreased Increased, Decreased,
normal
normal
normal
Decreased,
Decreased Decreased Increased
normal

normalized as well. Correcting the volume status
improves the metabolic alkalosis and inactivates
the renin-angiotensin axis, allowing successful
potassium repletion.
A good rule of thumb is that every decrease of
1 mmol/L in the serum potassium level represents a loss of 100–150 mmol in total body potassium. For repletion, oral potassium chloride is
generally preferred. Typically, potassium is administered in a split dose of 40–80 mEq/day for
a few days, with subsequent measurements of the
potassium level to ensure normalization.
Another manifestation of pseudo-Bartter’s syndrome is the development of lower extremity
edema in those who purge excessively via vomiting, laxatives, or diuretics and then abruptly
stop. The unopposed high levels of aldosterone,
caused by the abrupt cessation of purging, can
cause marked salt retention and edema. Attempts
to self-treat this condition with diuretics will exacerbate the problem. Salt restriction, lower extremity elevation, and patience are usually all
that is necessary to resolve this problem. Occasionally, it is prudent to prescribe a short, 2-week
course of a potassium-sparing diuretic, such as
spironolactone, to negate the effects of aldosterone and treat the edema, particularly when
the distress over edema threatens a relapse in the
patient’s bulimic behaviors.

Oral complications
The most obvious oral health disorder seen in
bulimia is tooth enamel erosion (perimyolysis).
This erosion occurs primarily on the lingual and
occlusal surfaces of the maxillary dentition but
may also be seen on the facial surfaces in later
stages of disease. The erosion is caused by regurgitation of acidic gastric contents on a repeti-

Urine
pH
(7.38–7.42)

Sodium

Potassium

Chloride

Increased

Decreased

Increased

Decreased

Decreased

Decreased

Decreased

Normal

Increased

Increased

Increased

Increased

tive basis during self-induced vomiting. The low
pH of gastric contents is below the critical threshold for enamel mineralization.22 Enamel erosion
is usually seen after 6 months of self-induced
vomiting and is ubiquitous in those who have
had the disorder for 5 years.23 Erosion may
cause thermal tooth hypersensitivity from dentin
exposure. Unfortunately, once tooth enamel is
eroded, it will not regenerate, and restorative
dental procedures may be necessary. It remains
controversial whether the mechanical abrasion
from toothbrushing immediately after vomiting
worsens this erosion, and several experts recommend mouthwashing with neutralizing solutions, such as sodium bicarbonate.22
Despite commonly bingeing with foods high in
carbohydrate and fat content, patients with bulimia have lower rates of dental caries, plaque,
and periodontal disease. This may be the result
of compulsive oral hygiene practices in this population.24
Parotid gland enlargement (sialadenosis) is a
particularly bothersome disorder seen in patients
with bulimia. Enlargement occurs not immediately but after a patient has been in the bingepurge cycle for some time. Once enlargement occurs, however, it can reappear quickly when
vomiting resumes. The prevalence of parotid enlargement is estimated to be between 10% and
50% in bulimic patients and occasionally involves
swelling of the submandibular glands. Clinically,
the swelling develops 3–6 days after a bingepurge episode has stopped, and its severity is
thought to be related to the frequency of vomiting behavior. The swelling is usually painless but
can be quite disfiguring and, therefore, emotionally disturbing to a patient who is already selfconscious about her physical appearance.
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Histologically, parotid gland enlargement is
noninflammatory, but the glands exhibit an increase in acinar size and in the number of secretory granules. The mechanism of this enlargement is not entirely clear, but theories include:
1. Work hypertrophy, where repeated chewing
and intake of carbohydrate-rich food hyperstimulate glands
2. Autonomic stimulation of salivary glands by
pancreatic proteolytic enzymes brought into
the mouth during emesis, which stimulate lingual taste receptors
3. Cholinergic stimulation of salivary glands by
vomitus, increasing saliva production and secretion, which causes acinar hypertrophy
Treatment of parotid gland enlargement begins
with cessation of self-induced vomiting, heat applications, and the use of sialagogues, such as tart
candy. For patients unresponsive to these measures, pilocarpine hydrochloride tablets (5 mg
three times per day) may be useful.25 In unresponsive cases, parotidectomy is an option but
may cause worsened cosmetic deformity and is
rarely indicated.
Erythema of the oral mucosa occurs as a consequence of chronic irritation from vomited gastric contents. Frequently, patients will complain
of pharyngeal, palatal, and gingival soreness.
Cheilosis is characterized by pallor, maceration,
and in severe cases, painful fissures involving the
angles of the mouth. Vitamin B12 deficiency
should be excluded, and efforts should be made
toward correction of the primary oral abnormality to maintain lip hygiene and prevent leakage
of saliva through the corners of the mouth.

Gastrointestinal effects
The two main sites in the gastrointestinal tract
affected by bulimia are the esophagus and colon.
Esophageal involvement is found in patients who
purge through self-induced vomiting. Depending
on the frequency of vomiting, which can range
from once to more than 10 times a day, the result
may be esophagitis, esophageal ulcers, strictures,
or rupture.
Although rare, esophageal rupture (Boerhaave’s syndrome) in bulimia is life threatening;
the overall mortality is approximately 20%. Early
surgical intervention, however, is generally curative. The presentation includes severe chest pain,

MEHLER ET AL.

mediastinitis, and pleural effusions; if the diagnosis is delayed, tachycardia and hypotension
may develop.
Barrett’s esophagus, in which columnar epithelium replaces normal squamous epithelium
as a result of chronic irritation from recurrent reflux or vomiting of acidic stomach contents, has
also been described in bulimia. Esophageal adenocarcinoma develops in approximately 0.5% of
patients with Barrett’s esophagus per year.26
Esophageal complications give rise to frequent
complaints of sore throat, dyspepsia, dysphagia,
or hematemesis.27 The last is usually the result of
Mallory-Weiss tears or esophagitis. Spontaneous
reflux of gastric contents into the lower esophagus can also occur and causes significant heartburn as a result of laxity of the lower esophageal
sphincter after months of repeated vomiting.
Treatment for esophageal complications of bulimia is similar to that for gastroesophageal reflux disease. Acid suppression with a proton
pump inhibitor is of value in this regard. In the
patient who tends to vomit spontaneously, a prokinetic agent, such as metoclopramide, is worth
considering. It acts by increasing lower esophageal sphincter tone and hastening gastric emptying and, hence, can be a useful adjunct in severely affected patients.
Patients with bulimia nervosa who purge
through laxatives may also experience complaints
referable to the colon.28 Some patients may ingest
up to 50 laxative pills per day to achieve their desired result. A review of 73 studies of laxative
abuse revealed a lifetime incidence of 27.2%
among patients with bulimia nervosa compared
with 4.18% in the general population. Chronic
abuse of stimulant cathartics (compounds containing senna or cascara) can cause melanosis coli
(a reversible brown-black discoloration of the
colonic mucosa and submucosa), a benign finding.
In addition, these patients can develop an atonic
colon, resulting in chronic constipation and laxative dependence, or a cathartic colon, a permanently flaccid and dilated colon that cannot propagate fecal material, resulting from damage to the
neurological innervation of the intestine. Cathartic colon may cause refractory constipation requiring bowel resection.29 A previously abused
stimulant laxative, phenolphthalein, was removed
from the market a few years ago because of concern about its association with colon cancer.
Constipation is particularly problematic during attempts to withdraw stimulant laxatives in
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a bulimic patient.30 Laxative withdrawal is best
managed by anticipatory counseling, including
setting the expectation that constipation and possibly rebound edema may occur but typically resolve within 10 days to 3 weeks. Patients should
also be advised that regular exercise, adequate
fluid intake, the addition of such bulk-forming
agents as fiber or psyllium to the diet, and in some
cases, an osmotic laxative, such as lactulose, will
be necessary. Stool softeners are of little clinical
value.31
Patients’ misconceptions about stimulant laxatives should be addressed. Moreover, they should
be told that laxatives are an ineffective means of
weight loss because their site of action is the large
intestine, where they cause temporary fluid loss
without concomitant caloric losses. Relapse to
stimulant laxative abuse will worsen the dependency on them and increase the risk of more refractory constipation. Steatorrhea, protein-losing
gastroenteropathy, and gastrointestinal bleeding
have also been reported as a result of laxative
abuse.

Cardiovascular complications
Cardiovascular complications occasionally result from the purging behaviors used by bulimics. Excessive purging of any type may cause volume depletion, which can cause dizziness,
hypotension, or even syncope. Purging may also
cause hypokalemia, which can lead to arrhythmias. The repeated use of ipecac to induce vomiting can cause an irreversible and potentially fatal cardiomyopathy. Ipecac is usually sold in
bottles containing 30 ml of syrup of ipecac, the
equivalent of 21 mg of emetine base, which is the
toxic component. An estimated total dose of 1.25
g of emetine base may be fatal,32 and lesser doses
may cause skeletal and cardiac muscle myopathy. The drug is excreted slowly, so accumulation
over time is a major concern. Mitral valve prolapse may be more prevalent among bulimic women and usually resolves with weight gain. On
occasion, these patients may complain of palpitations or even chest pain as a result thereof and,
similarly, if ephedrine-type diet supplements are
abused.

Endocrine effects
There appears to be an increased prevalence of
bulimia in patients with insulin-dependent diabetes.33 Such patients may deliberately omit or re-

duce their insulin injections to induce diuresis
and weight loss. In this regard, some of the behaviors that are important in dietary management of diabetes may set the stage for an eating
disorder. Specifically, traditional dietary regimens that limit sweets teach patients to avoid certain foods and may thus promote abnormal eating habits. Although the causal relationship
between bulimia and diabetes is debated, the
detrimental effects of this combination are clear.
In diabetic patients with bulimia, end-organ damage develops at a younger age than in agematched nonbulimic diabetic patients.34 Glycosylated hemoglobin values are elevated in many
diabetic patients with bulimia because of the
metabolic effects of binge eating, noncompliance
with dietary regimens, and deliberate omission of
insulin in order to produce an osmotic diuresis
and weight loss.
In contrast to anorexia nervosa, other endocrine manifestations are not prominent in bulimia.35 Compared with the general population,
persons with bulimia nervosa appear to have a
higher prevalence of nonsuppression on the dexamethasone suppression test, ranging between
20% and 67% in different studies.18 This lack of
suppression remains unexplained. Oligomenorrhea may occur in bulimia nervosa during
episodes of active bulimia, but amenorrhea is infrequent.14 This is in marked contrast to anorexia
nervosa, where amenorrhea is a universal finding. The future ability of bulimic patients to conceive does not appear to be impaired.36 Of note,
although many women with bulimia will have reduced symptomatology during pregnancy, this is
often followed by an exacerbation of symptoms
after delivery.37
Similarly, in contrast to anorexia, wherein the
prevalence of osteoporosis is very high,38 bone
density is generally normal in bulimic patients
unless there has been a prior history of anorexia
nervosa and marked weight loss. In this instance,
bone densitometry would be warranted. Russell’s
sign, that is, erosions covering the dorsum of the
hands, is a result of using one’s finger to self-induce vomiting.39

SITE OF TREATMENT
Most medical complications of bulimia can be
treated in the outpatient setting by a primary care
doctor or provider with expertise in dealing with
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these patients. Primary care providers should use
a multidisciplinary approach when managing
these patients, especially the more severe cases.
The team should include a psychologist/psychiatrist and a nutritionist. Patients with severe bulimia nervosa may benefit from a referral to a center specializing in eating disorders. The main role
of the primary care provider is to screen for and
diagnose the disorder and then manage any medical complications that arise while the patient is
engaged in therapy.
Factors that suggest a need for hospitalization
include severe depression, marked dehydration
and disabling symptoms, purging that is rapidly
worsening and has proved refractory to outpatient treatment, severe hypokalemia (plasma
potassium level 2.0–3.0 mmol/L), and major orthostatic changes in blood pressure (30 mm Hg)
and pulse (30 beats per minute). Data are lacking on how these factors affect the ultimate outcome.40

SUMMARY
Bulimia nervosa is an increasingly common
disorder among young women, especially in industrialized countries. Not only can it have adverse physical effects, but it can also wreak havoc
on the emotional and social lives of these patients.
The physical signs of this disorder can be subtle
and easily overlooked unless specifically sought.
Likewise, normal laboratory abnormalities are
unreliable for excluding the disorder. The art
of medicine comes into play in the evaluation
and treatment of persons with bulimia nervosa.
Adopting an accepting rather than a judgmental
attitude will aid the clinician in establishing trust
with the patient, eliciting the historical details
necessary to make the diagnosis, and offering the
necessary medical treatment to negate the litany
of medical complications that can occur with bulimia.
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